Mice Overexpressing Both Non-Mutated Human SOD1 and Mutated SOD1(G93A) Genes: A Competent Experimental Model for Studying Iron Metabolism in Amyotrophic Lateral Sclerosis.

New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis. J Cell Sci (2016) 0.77

Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem (1969) 43.83

Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem (1971) 28.59

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 18.08

The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta (1996) 6.15

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet (1996) 4.77

Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med (2002) 4.70

Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol (2009) 3.73

Regulation of ferritin genes and protein. Blood (2002) 3.27

Hepcidin and iron homeostasis. Biochim Biophys Acta (2012) 2.96

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol (2008) 2.76

Ceruloplasmin metabolism and function. Annu Rev Nutr (2002) 2.52

Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab (2008) 2.34

Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron. Blood (1999) 2.13

Ferritin and the response to oxidative stress. Biochem J (2001) 1.88

Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta (2006) 1.73

Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome. EMBO J (2006) 1.66

Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J (1995) 1.56

Compartment-specific protection of iron-sulfur proteins by superoxide dismutase. J Biol Chem (2003) 1.54

Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood (2010) 1.51

Mechanisms of mammalian iron homeostasis. Biochemistry (2012) 1.51

Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem (2009) 1.40

Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J (2006) 1.31

Haem oxygenase-1: non-canonical roles in physiology and pathology. Clin Sci (Lond) (2012) 1.19

Oxidative stress induces activation of a cytosolic protein responsible for control of iron uptake. Arch Biochem Biophys (1995) 1.16

Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem (2013) 1.15

Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One (2012) 1.13

Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull (2003) 1.12

Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve (2010) 1.09

Coupling heme and iron metabolism via ferritin H chain. Antioxid Redox Signal (2013) 1.08

Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis. FASEB J (2009) 1.03

Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci (2009) 1.03

Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul Disord (2005) 1.02

Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun (2006) 0.99

Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci (2011) 0.96

The IRP/IRE system in vivo: insights from mouse models. Front Pharmacol (2014) 0.96

Recycling of RNA binding iron regulatory protein 1 into an aconitase after nitric oxide removal depends on mitochondrial ATP. J Biol Chem (2002) 0.95

Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: a study of L5178Y mouse lymphoma cell lines differentially sensitive to H(2)O(2). Blood (2000) 0.94

Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J Neurol Sci (1995) 0.93

Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscul Dis (2012) 0.91

Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. J Neurochem (2001) 0.90

Absence of the iron-containing superoxide dismutase in mitochondria from mustard (Brassica campestris). Biochem J (1981) 0.89

Superoxide dismutase 1 modulates expression of transferrin receptor. J Biol Inorg Chem (2006) 0.86

Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis. Neurodegener Dis (2011) 0.86

Amyotrophic lateral sclerosis and skeletal muscle: an update. Mol Neurobiol (2013) 0.84

Review: iron metabolism and the role of iron in neurodegenerative disorders. Neuropathol Appl Neurobiol (2014) 0.84

Ferroportin expression in haem oxygenase 1-deficient mice. Biochem J (2013) 0.84

Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. J Magn Reson Imaging (2013) 0.83

Haemolytic anaemia and alterations in hepatic iron metabolism in aged mice lacking Cu,Zn-superoxide dismutase. Biochem J (2009) 0.82

Differential expression of ceruloplasmin isoforms in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Proteomics Clin Appl (2008) 0.82

Down-regulation of iron regulatory protein 1 activities and expression in superoxide dismutase 1 knock-out mice is not associated with alterations in iron metabolism. J Biol Chem (2004) 0.82

Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis. Neuroscience (2012) 0.81

STAT5 proteins are involved in down-regulation of iron regulatory protein 1 gene expression by nitric oxide. Biochem J (2006) 0.79

Heme oxygenase in the experimental ALS mouse. Exp Neurol (1998) 0.78

Up-regulation of ferritin ubiquitination in skeletal muscle of transgenic rats bearing the G93A hmSOD1 gene mutation. Neuromuscul Disord (2009) 0.76

Changes in skeletal muscle iron metabolism outpace amyotrophic lateral sclerosis onset in transgenic rats bearing the G93A hmSOD1 gene mutation. Free Radic Res (2014) 0.76

Iron accumulation promotes TACE-mediated TNF-α secretion and neurodegeneration in a mouse model of ALS. Neurobiol Dis (2015) 0.76

Mottled Mice and Non-Mammalian Models of Menkes Disease. Front Mol Neurosci (2015) 0.75